EBI-005: Clinical Trials

2 trials of EBI-005, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1
Phase 11Completed 1

Follow EBI-005: new trials by email Literature Review of EBI-005 trials Research Report on EBI-005

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
isunakinra - Colorectal Cancer Metastatic
Phase 2RecruitingBuzzard Pharmaceuticals202025-01-302026-10-23
Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumors
Isunakinra, PD-(L)1 Inhibitor - Solid Tumor, Adult
Phase 1 / Phase 2CompletedBuzzard Pharmaceuticals152020-09-012024-08-06

Conditions studied

Colorectal Neoplasms (1)  ·  Neoplasm Metastasis (1)

Sponsors

Buzzard Pharmaceuticals (2)

Countries

United States (2)

Top investigators

Maarten de Chateau, MD, PhD (1)